|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12Q 1/68 | (2006.01) |
| A61K 38/50 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2147122 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08754910.1 |
| Date of filing the European patent application | 2008-04-18 | |
| (97) | Date of publication of the European application | 2010-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2014-07-16 |
| (46) | Date of publication of the claims translation | 2014-12-29 |
| (86) | Number | PCT/US2008/060733 |
| Date | 2008-04-18 |
| (87) | Number | WO 2008/131163 |
| Date | 2008-10-30 |
| (30) | Number | Date | Country code |
| 913039 P | 2007-04-20 | US |
| (72) |
FILPULA, David R., US
SAPRA, Puja, US
|
| (73) |
UNIKERIS LIMITED,
333 Styal Road, Manchester M22 5LG,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Fermentinė priešvėžinė terapija |
| ENZYMATIC ANTICANCER THERAPY |
| Payment date | Validity (years) | Amount | |
| 2026-03-31 | 19 | 347.00 EUR |
| 2027-04-18 |